Aleksandar Danilovski
Directeur/Membre du Conseil chez ACTIVE BIOTECH AB
Profil
Aleksandar Danilovski is the founder of Dalisco doo, a company founded in 2023, where he holds the title of Managing Partner.
He is currently working as an Independent Director at Active Biotech AB since 2020, as a Director at Pharmaero ApS, and as the Chief Scientific Officer at Xellia Pharmaceuticals ApS since 2009.
In his former positions, he worked as a Principal at PLIVA, Inc., Head-European Research & Development at Barr Laboratories, Inc., Member-Management Board at PLIVA Pharmaceuticals, Inc., Principal at The Barr Group, Inc., and Member-Management Board at PLIVA Croatia Ltd.
from 2011 to 2012.
He also served as a Member-Scientific Selection Board at Novo Holdings A.
Dr. Danilovski obtained a doctorate degree from the University of Cambridge and holds undergraduate and doctorate degrees from the University of Zagreb.
Postes actifs de Aleksandar Danilovski
| Sociétés | Poste | Début |
|---|---|---|
| ACTIVE BIOTECH AB | Directeur/Membre du Conseil | 01/01/2020 |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
| Pharmaero ApS | Directeur/Membre du Conseil | - |
Anciens postes connus de Aleksandar Danilovski
| Sociétés | Poste | Fin |
|---|---|---|
| PLIVA Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Corporate Officer/Principal | - |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Corporate Officer/Principal | - |
| PLIVA Croatia Ltd. | Directeur/Membre du Conseil | - |
| The Barr Group, Inc. | Corporate Officer/Principal | - |
Formation de Aleksandar Danilovski
| University of Cambridge | Doctorate Degree |
| University of Zagreb | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Entreprise privées | 8 |
|---|---|
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Health Technology |
| PLIVA Pharmaceuticals, Inc. | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Services |
| The Barr Group, Inc. | |
| PLIVA Croatia Ltd. | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
| Pharmaero ApS |
